Taiga Nishihori Selected Research

Taiga Nishihori Research Topics

Disease

42	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2024 - 02/2011
37	Multiple Myeloma 12/2023 - 10/2011
35	Neoplasms (Cancer) 12/2023 - 11/2002
19	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 10/2022 - 06/2014
17	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 02/2024 - 10/2010
14	Lymphoma (Lymphomas) 01/2023 - 09/2013
12	Infections 12/2023 - 09/2013
12	Leukemia 10/2022 - 06/2015
11	B-Cell Lymphoma (Lymphoma, B Cell) 01/2023 - 01/2020
10	Hematologic Neoplasms (Hematological Malignancy) 11/2023 - 01/2017
8	Cytokine Release Syndrome 11/2023 - 01/2020
8	Bronchiolitis Obliterans Syndrome 11/2022 - 10/2010
7	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 11/2022 - 03/2016
6	Plasma Cell Leukemia 01/2023 - 12/2011
4	Cytopenia 02/2024 - 09/2013
4	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2024 - 11/2014
4	Primary Myelofibrosis (Myelosclerosis) 07/2023 - 11/2010
4	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 12/2020 - 01/2016
3	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 05/2024 - 10/2015
3	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 01/2023 - 10/2015
3	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 11/2021 - 10/2015
3	Hodgkin Disease (Hodgkin's Disease) 01/2021 - 10/2015
3	Pathologic Complete Response 01/2020 - 03/2016
3	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2019 - 01/2018
3	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2018 - 06/2015
2	Residual Neoplasm 02/2024 - 04/2016
2	Renal Insufficiency (Renal Failure) 08/2023 - 09/2013
2	Cardiovascular Diseases (Cardiovascular Disease) 04/2023 - 01/2023
2	Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic) 01/2023 - 05/2017
2	Amyloidosis 01/2022 - 11/2015
2	Immunoglobulin Light-chain Amyloidosis 01/2022 - 01/2022
2	T-Cell Prolymphocytic Leukemia (Leukemia, T Cell, Chronic) 01/2022 - 01/2018
2	Cytomegalovirus Infections (Inclusion Disease) 10/2021 - 01/2015
2	Chromosome Aberrations (Chromosome Abnormalities) 01/2021 - 01/2020
2	Thrombotic Microangiopathies 01/2020 - 09/2011
1	Critical Illness (Critically Ill) 08/2023
1	Inflammation (Inflammations) 04/2023

Drug/Important Bio-Agent (IBA)

16	Cyclophosphamide (Cytoxan)FDA LinkGeneric 11/2023 - 10/2015
13	Tacrolimus (Prograf)FDA LinkGeneric 01/2024 - 12/2012
12	Chimeric Antigen ReceptorsIBA 01/2024 - 01/2021
11	Melphalan (Alkeran)FDA LinkGeneric 07/2023 - 06/2012
9	Busulfan (Busulfex)FDA Link 07/2023 - 10/2010
8	fludarabineIBA 07/2023 - 02/2011
8	axicabtagene ciloleucelIBA 01/2023 - 01/2020
8	Methotrexate (Mexate)FDA LinkGeneric 01/2019 - 12/2012
7	Bortezomib (Velcade)FDA Link 01/2023 - 06/2012
7	Lenalidomide (CC 5013)FDA Link 01/2023 - 09/2013
7	Calcineurin InhibitorsIBA 01/2021 - 09/2011
6	Sirolimus (Rapamycin)FDA Link 11/2023 - 09/2011
6	GlucocorticoidsIBA 11/2022 - 10/2010
6	Rituximab (Mabthera)FDA Link 01/2020 - 02/2011
5	AntigensIBA 11/2023 - 09/2013
5	Dexamethasone (Maxidex)FDA LinkGeneric 01/2022 - 01/2014
4	Mycophenolic Acid (Cellcept)FDA LinkGeneric 11/2023 - 01/2019
4	idecabtagene vicleucelIBA 10/2023 - 12/2022
3	bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA 12/2023 - 01/2023
3	Interleukin-6 (Interleukin 6)IBA 11/2023 - 01/2021
3	SteroidsIBA 01/2021 - 11/2014
3	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 01/2020 - 01/2016
3	Alemtuzumab (Campath)FDA Link 01/2020 - 09/2013
3	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2019 - 10/2015
2	Proteins (Proteins, Gene)FDA Link 01/2024 - 01/2023
2	VaccinesIBA 11/2023 - 09/2013
2	Ferritins (Ferritin)IBA 10/2023 - 01/2021
2	B-Cell Maturation AntigenIBA 09/2023 - 01/2023
2	LigandsIBA 01/2023 - 01/2021
2	tocilizumab (atlizumab)FDA Link 01/2023 - 01/2021
2	tisagenlecleucelIBA 01/2023 - 01/2021
2	Proteasome InhibitorsIBA 01/2023 - 10/2015
2	ofatumumab FDA Link 11/2022 - 06/2015
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2021 - 01/2021
2	InterferonsIBA 01/2021 - 10/2005
2	Tyrosine Kinase InhibitorsIBA 01/2020 - 01/2020
2	Etoposide (VP 16)FDA LinkGeneric 01/2019 - 10/2015
2	liposomal doxorubicin (Doxil)FDA Link 11/2015 - 01/2014
2	Glucose (Dextrose)FDA LinkGeneric 09/2015 - 02/2011
1	venetoclaxIBA 02/2024
1	AlbuminsIBA 12/2023
1	SurvivinIBA 11/2023
1	Protein Isoforms (Isoforms)IBA 11/2023
1	pembrolizumabIBA 11/2023
1	C-Reactive ProteinIBA 10/2023
1	CytokinesIBA 04/2023
1	Biomarkers (Surrogate Marker)IBA 04/2023
1	CreatinineIBA 04/2023
1	Troponin IIBA 04/2023
1	Interleukin-15 (Interleukin 15)IBA 04/2023

Therapy/Procedure

106	Cell Transplantation 05/2024 - 10/2010
56	Therapeutics 01/2024 - 10/2005
31	Transplantation 11/2023 - 02/2011
17	Homologous Transplantation 01/2023 - 10/2010
16	Hematopoietic Stem Cell Transplantation 01/2023 - 11/2011
12	Drug Therapy (Chemotherapy) 11/2023 - 09/2015
12	Autologous Transplantation 01/2023 - 09/2013
6	Stem Cell Transplantation 01/2023 - 01/2019
4	Immunotherapy 04/2023 - 09/2013
2	Critical Care (Surgical Intensive Care) 12/2023 - 08/2023
2	Artificial Respiration (Mechanical Ventilation) 01/2023 - 10/2022
2	Photopheresis 10/2017 - 11/2014
1	Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation) 11/2023